Skip to content

Panbela Therapeutics, Inc.: filings

Every Panbela Therapeutics, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 48 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2024-11-14fiscal Q3 202431960001437749-24-035315
10-Q2024-08-13fiscal Q2 202431930001437749-24-026462
10-Q2024-05-15fiscal Q1 202430630001437749-24-017064
10-K2024-03-26fiscal FY 202334680001437749-24-009418
10-Q2023-11-09fiscal Q3 202331960001437749-23-031265
10-Q2023-08-10fiscal Q2 202331920001437749-23-023053
10-Q2023-05-04fiscal Q1 202330620001437749-23-012574
10-K2023-03-16fiscal FY 202233650001437749-23-006899
10-Q2022-11-10fiscal Q3 202231960001437749-22-026909
10-Q2022-08-15fiscal Q2 202231920001437749-22-020539
10-Q2022-05-12fiscal Q1 202229600001437749-22-012129
10-K2022-03-24fiscal FY 202129590001437749-22-007101
10-Q2021-11-10fiscal Q3 202127840001437749-21-026149
10-Q2021-08-11fiscal Q2 202126760001437749-21-019460
10-Q2021-05-12fiscal Q1 202126540001437749-21-011830
10-K2021-03-25fiscal FY 202027550001437749-21-007154
10-Q2020-11-12fiscal Q3 202026800001437749-20-023614
10-Q2020-08-11fiscal Q2 202026770001437749-20-017410
10-Q2020-05-12fiscal Q1 202026570001437749-20-010432
10-K2020-03-24fiscal FY 201928580001437749-20-005968
10-Q2019-11-13fiscal Q3 201927850001437749-19-022592
10-Q2019-08-13fiscal Q2 201927810001437749-19-016431
10-Q2019-05-14fiscal Q1 201926570001437749-19-009730
10-K2019-03-22fiscal FY 201827560001437749-19-005461
10-Q2018-11-05fiscal Q3 201826720001437749-18-019460
10-Q2018-08-13fiscal Q2 201826710001437749-18-015265
10-Q2018-05-14fiscal Q1 201826530001437749-18-009655
10-K2018-03-21fiscal FY 201725530001437749-18-005094
10-Q2017-11-14fiscal Q3 201724680001437749-17-019211
10-Q2017-08-10fiscal Q2 201722640001437749-17-014343
10-Q2017-05-11fiscal Q1 201722460001437749-17-008685
10-K2017-03-30fiscal FY 201624500001437749-17-005554
10-Q2016-11-10fiscal Q3 201622630001437749-16-041662
10-Q2016-08-11fiscal Q2 201622630001437749-16-037081
10-Q2016-05-12fiscal Q1 201621440001437749-16-031586
10-K2016-03-08fiscal FY 201524500001437749-16-027017
10-Q2015-11-16fiscal Q3 201523660001437749-15-020830
10-Q2015-08-13fiscal Q2 201527700001477932-15-005076
10-Q2015-05-15fiscal Q1 201526520001477932-15-003245
10-K2015-03-30fiscal FY 201433660001477932-15-001973
10-Q2014-11-14fiscal Q3 201428710001477932-14-006173
10-Q2014-08-14fiscal Q2 201428720001477932-14-004417
10-Q2014-05-15fiscal Q1 201427540001477932-14-002612
10-K2014-03-28fiscal FY 201338750001477932-14-001315
10-Q2013-11-14fiscal Q3 201332870001477932-13-005487
10-Q2013-08-14fiscal Q2 201332870001477932-13-003683
10-Q2013-05-15fiscal Q1 201329570001477932-13-002447
10-K2013-03-26fiscal FY 201235710001477932-13-001328

Inspect the source

Entity
Panbela Therapeutics, Inc. / CIK 0001029125
Captured
2026-09-21T17:17:41.392Z
SEC response SHA-256
5fda5ff967a840ef3f57f70eeef789c92fe69418b24473bec9634b9f66bd5e2d

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001029125.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))